Spleen Tyrosine Kinase Inhibitors for Rheumatoid Arthritis: Where Are We Now?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spleen Tyrosine Kinase Inhibitors for Rheumatoid Arthritis: Where Are We Now?
Authors
Keywords
Rheumatoid Arthritis, Adalimumab, Minimal Clinically Important Difference, Tumour Necrosis Factor Inhibitor, Health Assessment Questionnaire
Journal
DRUGS
Volume 74, Issue 4, Pages 415-422
Publisher
Springer Nature
Online
2014-03-07
DOI
10.1007/s40265-014-0193-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OP0048 OSKIRA-4: A Phase IIB Randomised, Placebo-Controlled Study of the Efficacy and Safety of Fostamatinib Monotherapy
- (2014) P. C. Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
- (2014) Cécile Gaujoux-Viala et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis
- (2013) Eva Salgado et al. ANNALS OF THE RHEUMATIC DISEASES
- Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo-Controlled Trial
- (2013) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
- (2013) Ying He et al. BMC MUSCULOSKELETAL DISORDERS
- Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of Patient-reported Outcomes from a Randomized, Double-blind, Placebo-controlled Trial
- (2013) M. E. Weinblatt et al. JOURNAL OF RHEUMATOLOGY
- Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
- (2013) Gerd R Burmester et al. LANCET
- Novel small molecule therapeutics in rheumatoid arthritis
- (2013) V. Kelly et al. RHEUMATOLOGY
- Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis
- (2013) J. S. Nijjar et al. RHEUMATOLOGY
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
- (2012) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years
- (2011) M. U. Rahman et al. ANNALS OF THE RHEUMATIC DISEASES
- Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase
- (2011) S. Kazerounian et al. BLOOD
- Biologics-Based Therapy for the Treatment of Rheumatoid Arthritis
- (2011) D L Scott CLINICAL PHARMACOLOGY & THERAPEUTICS
- An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents
- (2010) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
- (2010) Michael E. Weinblatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- "Go upstream, young man": lessons learned from the p38 saga
- (2009) D Hammaker et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis
- (2009) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial
- (2008) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Is there a future for small molecule drugs in the treatment of rheumatic diseases?
- (2008) Joanna Stanczyk et al. CURRENT OPINION IN RHEUMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started